Back
Akebia Therapeutics Stock Price Chart
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!
Buy
66
AKBA
Akebia Therapeutics
Last Price:
1.86
Seasonality Move:
32.87%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKBA is experiencing buying pressure, which is a positive indicator for future bullish movement.
Akebia Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.71 | Buy |
| 20-day SMA: | 1.52 | Buy |
| 50-day SMA: | 1.44 | Buy |
| 200-day SMA: | 1.39 | Buy |
| 8-day EMA: | 1.72 | Buy |
| 20-day EMA: | 1.58 | Buy |
| 50-day EMA: | 1.47 | Buy |
| 200-day EMA: | 1.34 | Buy |
Akebia Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.11 | Buy |
| Relative Strength Index (14 RSI): | 78.3 | Buy |
| Chaikin Money Flow: | 2495662 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.29 - 1.67) | Buy |
| Bollinger Bands (100): | (1.12 - 1.54) | Buy |
Akebia Therapeutics Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Akebia Therapeutics Stock
Is Akebia Therapeutics Stock a Buy?
- Akebia Therapeutics share price is 1.86 while AKBA 8-day simple moving average is 1.71, which is a Buy signal.
- The stock price of AKBA is 1.86 while Akebia Therapeutics 20-day SMA is 1.52, which makes it a Buy.
- Akebia Therapeutics 50-day simple moving average is 1.44 while AKBA share price is 1.86, making it a Buy technically.
- AKBA stock price is 1.86 and Akebia Therapeutics 200-day simple moving average is 1.39, creating a Buy signal.
AKBA Technical Analysis vs Fundamental Analysis
Buy
66
Akebia Therapeutics (AKBA)
is a Buy
Is Akebia Therapeutics a Buy or a Sell?
-
Akebia Therapeutics stock is rated a Buy
The current Akebia Therapeutics [AKBA] share price is $1.86. The Score for AKBA is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
Akebia Therapeutics Stock Info
Market Cap:
391.14M
Price in USD:
1.86
Share Volume:
2.5M
Akebia Therapeutics 52-Week Range
52-Week High:
2.48
52-Week Low:
0.80
Buy
66
Akebia Therapeutics (AKBA)
is a Buy
Akebia Therapeutics Share Price Forecast
-
What is the Akebia Therapeutics stock price today?
The Akebia Therapeutics stock price is 1.86 USD today. -
Will AKBA stock go up or go down?
Akebia Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Akebia Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Akebia Therapeutics is not overvalued.
Is Akebia Therapeutics Stock a Buy?
- Akebia Therapeutics share price is 1.86 while AKBA 8-day exponential moving average is 1.72, which is a Buy signal.
- The stock price of AKBA is 1.86 while Akebia Therapeutics 20-day EMA is 1.58, which makes it a Buy.
- Akebia Therapeutics 50-day exponential moving average is 1.47 while AKBA share price is 1.86, making it a Buy technically.
- AKBA stock price is 1.86 and Akebia Therapeutics 200-day simple moving average is 1.34, creating a Buy signal.
Fundamental Analysis of Akebia Therapeutics
Is Akebia Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and an increase next year of $0.01 per share.
Technical Analysis of Akebia Therapeutics
Should I short Akebia Therapeutics stock?
- AKBA Moving Average Covergence Divergence (MACD) indicator is 0.11, suggesting Akebia Therapeutics is a Buy
- Akebia Therapeutics Relative Strength Index (RSI) is 78.3, which suggest Akebia Therapeutics is overbought
- The Bollinger Bands (25) for Akebia Therapeutics is (1.29 - 1.67), which suggest Akebia Therapeutics is a Buy
- The Bollinger Bands (100) for Akebia Therapeutics is (1.12 - 1.54), which suggest Akebia Therapeutics is a Buy
* Akebia Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.